Iofetamine (123I)

What is Iofetamine (123I)?

Iofetamine (123I) is a crucial diagnostic radiopharmaceutical used in nuclear medicine, specifically for Single-Photon Emission Computed Tomography (SPECT imaging) of the brain. Also known as Iodine-123 Iofetamine, this agent contains a small, safe amount of the radioactive isotope Iodine-123. It allows medical professionals to visualize and assess regional cerebral blood flow, providing valuable diagnostic information to understand various neurological conditions by mapping blood supply to different brain regions. It is a diagnostic tool, not a treatment.

How Does it Work?

When administered intravenously, Iofetamine (123I) rapidly crosses the blood-brain barrier due to its lipophilic nature. Once inside the brain, it is retained in brain tissue in proportion to the regional cerebral blood flow. Areas with higher blood flow accumulate more of the radiopharmaceutical. The Iodine-123 isotope then emits gamma rays, which are detected by a SPECT scanner. These signals are processed to create detailed, three-dimensional images illustrating the distribution of blood flow, providing a functional map of brain activity and helping identify areas with abnormal perfusion.

Medical Uses

Iofetamine (123I) is primarily used for diagnostic purposes in neurology, complementing structural imaging techniques. Key applications include:

• Assessment of Stroke: Identifying areas of reduced blood flow (ischemia) due to stroke, even when structural scans appear normal.
• Localization of Epileptic Foci: Helping pinpoint seizure-generating areas in patients with intractable epilepsy, crucial for surgical planning.
• Differentiation of Dementia Types: Aiding in distinguishing between forms like Alzheimer's disease, frontotemporal, and vascular dementia by identifying characteristic patterns of reduced cerebral blood flow.
• Evaluation of Traumatic Brain Injury: Identifying perfusion deficits following head trauma.

Dosage

The administration of Iofetamine (123I) is a precise intravenous injection performed by trained healthcare professionals. The specific dosage is carefully calculated based on the patient's body weight and the diagnostic protocol, typically ranging from 111 MBq to 222 MBq (3 to 6 mCi) for adults. Pediatric dosages are adjusted. Patients are often advised to hydrate adequately. After injection, a waiting period allows distribution before brain perfusion scan images are acquired using the SPECT scanner. Strict safety guidelines are followed to minimize radiation exposure.

Side Effects

Iofetamine (123I) is generally well-tolerated, with serious adverse reactions being rare. Most reported side effects are mild and transient. Common mild effects may include headache, dizziness, nausea, or injection site reactions. Allergic reactions are rare and typically mild (e.g., rash, itching); severe anaphylaxis is extremely uncommon. Due to Iodine-123, there is a small, controlled amount of radiation exposure, which is weighed against the diagnostic benefit, especially for pregnant or breastfeeding individuals. Patients should always inform their healthcare provider of any pre-existing conditions.

Drug Interactions

Significant drug interactions with Iofetamine (123I) are infrequent. As a diagnostic agent, it does not exert a pharmacological effect. However, medications that significantly alter cerebral blood flow could theoretically interfere with imaging results. For example, strong vasodilators or vasoconstrictors might affect the distribution pattern. Drugs affecting overall iodine kinetics are rarely a clinical concern for brain imaging. Patients must provide a complete list of all medications to their healthcare provider for accurate interpretation of the SPECT imaging results. Specific drug discontinuation is usually not required but should be confirmed.

FAQ

Is Iofetamine (123I) a treatment?

No, Iofetamine (123I) is solely a diagnostic agent used to visualize brain blood flow for diagnosis, not to treat conditions.

How long does the Iofetamine (123I) SPECT procedure take?

The injection is quick. After a waiting period of 15-45 minutes for distribution, the actual SPECT imaging takes approximately 20-40 minutes.

Are there any restrictions for pregnant or breastfeeding women?

Its use is generally contraindicated during pregnancy due to radiation risks to the fetus. Breastfeeding mothers may need to temporarily interrupt breastfeeding. Always discuss your status with your doctor.

Products containing Iofetamine (123I) are available through trusted online pharmacies. You can browse Iofetamine (123I)-based medications at ShipperVIP or Medicenter.

Summary

Iofetamine (123I) is a vital diagnostic radiopharmaceutical, utilizing Iodine-123 for detailed SPECT imaging of the brain. It offers critical insights into regional cerebral blood flow, making it indispensable for diagnosing conditions like stroke, epilepsy, and various dementias. Its ability to cross the blood-brain barrier provides a functional map of brain perfusion. While generally safe and well-tolerated, its administration requires careful medical oversight. As a powerful diagnostic tool, Iofetamine (123I) significantly enhances the understanding and management of complex neurological disorders.